Infosys gains nearly 1% on signing deal with Prime Therapeutics
Subscribe to GoodReturns
Shares of Infosys rose nearly 1 per cent in early trade on Bombay Stock Exchange (BSE) after it said that it signed a three-year contract with Prime Therapeutics to set up a testing centre of excellence (COE) and consolidate the delivery of its application testing services
The shares of company rose as much as 0.92 per cent to trade at Rs 3258.35 a piece on the BSE.
In a similar fashion, shares of the company rose 0.93 per cent to Rs 3261 a piece on National Stock Exchange.
Meanwhile, the broader benchmark Sensex was quoting at 22,253.12, up 38.75 points or 0.17 per cent at 10:42 hours.